Sorafenib is a kinase inhibitor drug approved for the treatment of primary kidney
cancer (advanced renal cell carcinoma), advanced primary liver cancer ...
Sorafenib (Nexavar) side effects, what it's used for, how it's given, how it works,
drug type, precautions and self care tips.
Apr 29, 2015 ... Read about the cancer treatment drug sorafenib, otherwise known as Nexavar,
including what it is, how it works and possible side effects.
Nov 26, 2013 ... On November 22, 2013, the Food and Drug Administration (FDA) approved
sorafenib tosylate (Nexavar<sup>®</sup> tablets, made by Bayer Healthcare ...
You should not use Nexavar if you are allergic to sorafenib, or if you have
squamous cell lung cancer and you are being treated with carboplatin (
Paraplatin) and ...
Easy to read patient leaflet for sorafenib. Includes indications, proper use, special
instructions, precautions, and possible side effects.
Sorafenib (Nexavar) is an orally active multikinase inhibitor that is approved in
the EU for the treatment of hepatocellular carcinoma. Monotherapy with sorafenib
Jan 13, 2016 ... Sorafenib (Nexavar®) is an oral multikinase inhibitor used in the treatment of liver
, kidney and thyroid cancers.
Sorafenib is a synthetic compound targeting growth signaling and angiogenesis.
Sorafenib blocks the enzyme RAF kinase, a critical component of the ...
Jul 24, 2008 ... Original Article from The New England Journal of Medicine — Sorafenib in
Advanced Hepatocellular Carcinoma.